Lymph Savior Official Website › Blog › Before the first trial
Why Burdock Root Was Called An ‘Alterative’ A Century Before Anyone Ran A Trial On It
This website's own red root article already noted, in a comparison table, that burdock root carries no human trial in any condition resembling what this bottle is sold for. That finding stands. What it leaves unanswered is the more interesting question: if burdock was never put through a modern trial for this use, why is it on a lymphatic-labelled bottle at all? The answer is over a century old, written down by name in 1898, and it has nothing to do with a trial.
- No modern human trial has tested burdock root for fluid, swelling or lymphatic flow; this website has already documented that gap in full elsewhere.
- Burdock's presence on a lymphatic-labelled formula traces to a nineteenth-century classification, not to a trial result.
- Felter and Lloyd's 1898 King's American Dispensatory lists burdock root as alterative, aperient, diuretic and sudorific, and discusses its use for scrofula, a historical term for tubercular swelling of the lymph glands.
- An alterative was a category of herb believed to gradually improve the body's elimination of waste through skin, kidneys and glands — a theory of disease, not a mechanism modern pharmacology recognises.
- Modern phytochemistry has characterised burdock's polyphenols and lignans thoroughly; none of that characterisation substitutes for the human trial that still does not exist.
A question the trial record cannot answer
This website's article on red root includes a table comparing the four botanicals on this label that are not horse chestnut or centella asiatica, scoring each for characterised chemistry, animal work and human trials. Burdock scores well on the first two counts and a plain no on the third: no human trial exists for burdock root in a condition resembling fluid, swelling or lymphatic flow. That is still true, and nothing in this article revisits it. What that earlier table does not explain is why burdock ended up in this formula's company at all, given that absence. The trial record cannot answer that question, because the decision to include burdock predates the trial record by well over a hundred years.
The Eclectic physicians, and the word alterative
The answer sits in a specific nineteenth-century American medical tradition: Eclectic medicine, a school of physicians active from roughly the 1830s through the early twentieth century who built a formal pharmacopoeia around botanical remedies, organised by category of action rather than by plant family. One of their central categories was the alterative — a group of herbs believed to work gradually, over weeks, to improve the body's processes of elimination through the skin, the kidneys, the liver and the lymphatic and glandular systems, correcting what the physicians of the time called a depraved state of the tissues. Burdock root was one of the Eclectic tradition's most frequently cited alteratives, and that single classification, carried forward through more than a century of herbal commerce, is the direct ancestor of why a burdock capsule can be sold today under a lymphatic strapline.
What King's American Dispensatory actually says about burdock
The primary text for this tradition is King's American Dispensatory, compiled by Harvey Wickes Felter, M.D., and John Uri Lloyd, Phr. M., Ph. D., and published in its major 1898 edition. Its entry for Arctium, burdock, states the plant's properties plainly: the root is described as alterative, aperient, diuretic and sudorific. The text goes on to describe burdock's reputation in skin disorders specifically, noting that conditions depending upon what the authors called a depraved state of the cutaneous tissues, rather than a disease confined to the skin itself, are conditions in which the plant has gained a reputation — among them psoriasis, chronic erysipelas, milk crust and eczema. Under its specific indications, the text lists feeble cutaneous circulation, scaly dry eruptions, impaired nutrition of the skin and urinary irritation as the signs that called for burdock in a nineteenth-century physician's practice.
Scrofula: the word that connects burdock to the lymphatic system
Among the conditions King's American Dispensatory and the broader Eclectic literature associate with burdock root decoction is scrofula — the historical term for tuberculous infection of the lymph nodes, typically in the neck, producing chronic, visibly swollen glands. Scrofula was a common and much-feared condition in the nineteenth century, long before antibiotic treatment for tuberculosis existed, and herbs reputed to resolve swollen glands, burdock prominent among them, were a standing part of the Eclectic physician's toolkit for it. This is the specific, documented thread connecting burdock root to the lymphatic and glandular system in the historical record: not a modern finding about lymphatic flow, but a nineteenth-century association between this root and visibly swollen lymph glands, treated as a category of skin-and-gland complaint the alteratives were believed to address together.
See how this label's six botanicals compare on the evidence
Characterised chemistry, animal work and human trials, scored out for all six botanicals in one table.
One, three and six-bottle packs · price set at checkout · 60-day money-back guarantee
Order Lymph Savior From This OutletLot LYM-26/LY-5684 · two a day, 60 to a bottle · ships from the United States
What an alterative was supposed to do, in nineteenth-century terms
It is worth being precise about what the word alterative meant to the physicians who used it, because the term has no equivalent in modern pharmacology and it is easy to misread it as a synonym for something more current. An alterative was not understood to act quickly or on a single organ. It was believed to work slowly, over a course of weeks, nudging the whole constitution's processes of elimination — sweat, urine, bile and, in the specific case of conditions like scrofula, the glandular and lymphatic routes — toward what the era called a more healthy action. The theory behind it belongs to a pre-microbial, pre-biochemical model of disease, in which illness was frequently understood as an accumulation of corrupted material that the body needed help clearing, rather than as an infection, a mechanical obstruction or a metabolic disorder in the modern sense. Burdock's reputation as an alterative is a faithful record of what nineteenth-century physicians believed the plant did; it is not, and was never intended as, a claim that would be tested the way a modern trial tests a treatment.
What modern phytochemistry has found since
The century and a quarter since King's American Dispensatory has not left burdock root uninvestigated; it has simply investigated it along different lines than the ones the Eclectic physicians were working from. A 2023 systematic review in the Journal of Ethnopharmacology catalogues the plant's phytochemistry in detail, including its polyphenols, chlorogenic acid and lignans such as arctiin and arctigenin. A separate 2024 review in Natural Products and Bioprospecting surveys burdock root's pharmacological properties across cell and animal studies, covering antioxidant, anti-inflammatory and metabolic effects. Both reviews are substantial, modern, peer-reviewed science, and neither one reports a human trial of burdock root for fluid, swelling, glandular complaints or lymphatic flow — the specific use case the nineteenth-century alterative tradition, and this label's own strapline, both point toward. Modern chemistry has characterised what is in the root far more precisely than Felter and Lloyd ever could; it has not yet tested, in people, the specific claim their tradition first made about it.
Why a tradition, however specific, is not a trial
It would be easy to read the detail in this article — a named text, a named condition, a documented category of practice — as a kind of evidence in its own right, and that would be a mistake this article wants to head off directly. A tradition tells you why a plant is on a label. It tells you what question, if any, a modern trial would need to answer to confirm or disconfirm the old physicians' belief. It does not answer that question itself. Nineteenth-century Eclectic physicians practised without blinding, without placebo comparison, and without the biochemical tools to separate a real effect from the natural course of a condition that often improved on its own. Scrofula, specifically, sometimes resolved without any treatment at all as a person's own immune response contained the infection, which means a nineteenth-century physician crediting burdock root for a glandular swelling that subsided could easily have been observing a coincidence rather than a cause.
The honest position on burdock, stated plainly
Put the two halves of this article's finding together and the honest position is straightforward. Burdock root's connection to the lymphatic system is real, documented and specific: a named nineteenth-century medical tradition, in a named text, associated this exact root with scrofula, the historical term for swollen lymph glands, as part of a broader category of herbs believed to support elimination through skin, kidneys and glands together. That connection is also, on its own, not evidence that the root does anything measurable for a modern reader's lymphatic health. The National Center for Complementary and Integrative Health's own guidance on using dietary supplements wisely makes the general version of this point: a long history of traditional use is a reason a plant was chosen, not a substitute for the kind of controlled human trial that would tell a reader whether the choice works.
Burdock is on this label because of an 1898 text, not a trial. The text is real and specific; it is also not the kind of evidence a trial would be.
References
- Felter HW, Lloyd JU. King's American Dispensatory, 18th ed. Arctium (Burdock). 1898. https://www.henriettes-herb.com/eclectic/kings/arctium.html
- Jin X, Liu S, Chen S, Wang L, Cui Y, He J, Fang S, Li J, Chang Y. A systematic review on botany, ethnopharmacology, quality control, phytochemistry, pharmacology and toxicity of Arctium lappa L. fruit. Journal of Ethnopharmacology. 2023;308:116223. https://pubmed.ncbi.nlm.nih.gov/36781057/
- Shyam M, Sabina EP. Harnessing the power of Arctium lappa root: a review of its pharmacological properties and therapeutic applications. Natural Products and Bioprospecting. 2024;14(1):49. https://pubmed.ncbi.nlm.nih.gov/39162715/
- Burdock. About Herbs, Memorial Sloan Kettering Cancer Center. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/burdock
- Herbs at a Glance. National Center for Complementary and Integrative Health, National Institutes of Health. https://www.nccih.nih.gov/health/herbsataglance